Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer Meeting Abstract


Authors: McDermott, R.; van Tilburg, C. M.; Farago, A. F.; Kummar, S.; Tan, D. S. W.; Albert, C. M.; Berlin, J.; Lassen, U. N.; Doz, F.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Reeves, J. A.; Dima, L.; Brega, N.; De La Cuesta, E.; Laetsch, T. W.; Hong, D. S.; Drilon, A.
Abstract Title: Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S1101
End Page: S1102
Language: English
ACCESSION: WOS:000573469102538
DOI: 10.1016/j.annonc.2020.08.1347
PROVIDER: wos
Notes: Meeting Abstract: 1955P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon